Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo

The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems

(2012) Alexandre Albanese et al.   Annual Review of Biomedical Engineering

Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

(2012) Che-Ming Jack Hu et al.   BIOCHEMICAL PHARMACOLOGY

Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis

(2012) Yujiang Fang et al.   CANCER SCIENCE

Drug interaction potential of resveratrol

(2012) Pascal Detampel et al.   DRUG METABOLISM REVIEWS

The dynamics of drug resistance: A mathematical perspective

(2012) Orit Lavi et al.   DRUG RESISTANCE UPDATES

Plasmonic gold and luminescent silicon nanoplatforms for multimode imaging of cancer cells

(2012) Folarin Erogbogbo et al.   Integrative Biology

Resveratrol and cellular mechanisms of cancer prevention

(2011) Yogeshwer Shukla et al.   Annals of the New York Academy of Sciences

The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells

(2011) Xiao-Xing Wang et al.   BIOMATERIALS

Heterogeneity Maintenance in Glioblastoma: A Social Network

(2011) R. Bonavia et al.   CANCER RESEARCH

Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy

(2011) Chung-Pu Wu et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel

(2011) Yongjin Liu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Nanoparticle PEGylation for imaging and therapy

(2011) Jesse V Jokerst et al.   Nanomedicine

The Phytoalexin Resveratrol Regulates the Initiation of Hypersensitive Cell Death in Vitis Cell

(2011) Xiaoli Chang et al.   PLoS One

Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression

(2010) Sin Ho Kweon et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Therapeutic Nanoparticles to Combat Cancer Drug Resistance

(2010) Che-Ming Hu et al.   CURRENT DRUG METABOLISM

Nanomedicinal strategies to treat multidrug-resistant tumors: current progress

(2010) Xiaowei Dong et al.   Nanomedicine

Resveratrol: a promising agent in promoting cardioprotection against coronary heart diseaseThis article is one of a selection of papers from the NATO Advanced Research Workshop on Translational Knowledge for Heart Health (published in part 2 of a 2-part Special Issue).

(2009) Suresh Varma Penumathsa et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Reversal effect of resveratrol on multidrug resistance in KBv200 cell line

(2008) Fang Quan et al.   BIOMEDICINE & PHARMACOTHERAPY

Multi-functional nanocarriers to overcome tumor drug resistance

(2008) Lara S. Jabr-Milane et al.   CANCER TREATMENT REVIEWS

Combination of antiangiogenesis with chemotherapy for more effective cancer treatment

(2008) J. Ma et al.   MOLECULAR CANCER THERAPEUTICS

ABC multidrug transporters: structure, function and role in chemoresistance

(2007) Frances J Sharom   PHARMACOGENOMICS